NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1154381929 MD
Verify on CMS → Russell Dambra, MD
Endocrinology, Diabetes & Metabolism Physician in New Hyde Park, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 520 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
62%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.1/100
▲ 6 pts above national avg 83.5 · Exceptional
Industry payments
$853.08
39 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Russell Dambra, MD reported a CMS MIPS final score of 89.1/100 - above the 83.5 national average - and filed 4,946 Medicare Part D claims in 2023.
- 89.1/100
- MIPS score · +6 vs avg
- 5K
- Part D claims, 2023
- 62%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1154381929 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ABOVE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1154381929
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-ABOVE 89.1/100
- RX-MID 4,946
- BOOK-LIGHT 797 in New York
- PHOTO-FINISH Harini Jalagani · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Evelyn Runer · l…
Evelyn Runer
88.8 MIPS pts
- Dambra · this pr…
Dambra · this provider
89.1 MIPS pts
- Harini Jalagani …
Harini Jalagani
89.1 MIPS pts
- Katharine Mikule…
Katharine Mikulec
89.2 MIPS pts
- Matthew Kamil · …
Matthew Kamil
89.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Russell Dambra, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
89 ≥ 56th percentile 56% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Russell Dambra, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Russell Dambra, MD writes more Part D claims than 81% of them and scores higher on MIPS quality than 59% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Russell Dambra, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Russell Dambra, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Russell Dambra, MD?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
4,946 87% vs specialty avg
MIPS final score
89.1/100 5.6 pts vs avg
Specialty distribution in New York
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Russell Dambra, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 89.1/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1154381929 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/25/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
89.0822
Final Score
Measured-score avg: 83.5
93.0245
Quality
53.9161
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Russell Dambra, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Optum Medical Care PC
Mount Kisco, NY
Prine Health Medical Group, PLLC
Manhasset, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Russell Dambra, MD. Source: openpaymentsdata.cms.gov.
Total received
$853
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Russell Dambra, MD. To verify Russell Dambra, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Russell Dambra, MD - brand share 33.0%
Endocrinology, Diabetes & Metabolism Physician average
33% brand-name claims vs 62% generic, on 4,946 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,946
Total Claims
$1.6M
Total Drug Cost
520
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 13,244
- Total Day Supply
- 395,768
- Brand vs Generic
- 33% brand / 62% generic
- Brand Drug Cost
- $1.4M
- Generic Drug Cost
- $121K
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 75.7 years
- Avg HCC Risk Score
- 1.37
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 15, 65-74: 213, 75-84: 238, 85+: 54
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Russell Dambra, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Synthroid
Synthroid
358 claims
- Levothyroxine Sodium
Levothyroxine Sodium
331 claims
- Metformin Hcl Er
Metformin Hcl Er
304 claims
- Glimepiride
Glimepiride
296 claims
- Pioglitazone Hcl
Pioglitazone Hcl
178 claims
- Metformin Hcl
Metformin Hcl
160 claims
- Atorvastatin Calcium
Atorvastatin Calcium
153 claims
- Rosuvastatin Calcium 129
Rosuvastatin Calcium
129 claims
| Drug | Claims |
|---|---|
| Synthroid Levothyroxine Sodium | 358 |
| Levothyroxine Sodium | 331 |
| Metformin Hcl Er Metformin Hcl | 304 |
| Glimepiride | 296 |
| Pioglitazone Hcl | 178 |
| Metformin Hcl | 160 |
| Atorvastatin Calcium | 153 |
| Rosuvastatin Calcium | 129 |
| Januvia Sitagliptin Phosphate | 125 |
| Ozempic Semaglutide | 102 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in NY →
All providers in New York →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Russell Dambra, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Russell Dambra, MD's 4,946 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Dambra, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (89.1 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Dambra.
One of 797 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New York, 5 are shown here.
Dr. Zinoviy Abelev
MD
Long Island City, NY
Dr. Jill Abelseth
M.D.
Albany, NY
Dr. Sherley Abraham
M.D.
New York, NY
Dr. Jennifer Abrams
DO
Brooklyn, NY
Dr. Naim Abrar
M.D.
Riverhead, NY
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Russell Dambra, MD's specialty? ▼
Russell Dambra, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in New Hyde Park, New York. Credentials: MD.
How much does Russell Dambra, MD prescribe under Medicare Part D? ▼
In 2023, Russell Dambra, MD wrote 4,946 Medicare Part D claims totaling $1.6M in drug costs for 520 beneficiaries.
What is Russell Dambra, MD's Medicare quality score? ▼
Russell Dambra, MD has a CMS MIPS Final Score of 89.1/100 (Quality: 93, Cost: 53.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Russell Dambra, MD located? ▼
Russell Dambra, MD is located at 3003 NEW HYDE PARK RD, New Hyde Park, NY, 11042. Phone: (516) 327-0850.
What is Russell Dambra, MD's NPI number? ▼
Russell Dambra, MD's National Provider Identifier (NPI) is 1154381929, issued on 03/25/2006.
Does Russell Dambra, MD prescribe more brand-name or generic drugs? ▼
Russell Dambra, MD's prescribing is 33% brand-name and 62% generic drugs by claim count, with $1.4M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Russell Dambra, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Russell Dambra, MD's most frequently prescribed drugs include Synthroid, Levothyroxine Sodium, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Russell Dambra, MD accept Medicare? ▼
Russell Dambra, MD appears in CMS Medicare data with 4,946 Part D claims and 520 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Russell Dambra, MD's credentials? ▼
Russell Dambra, MD's NPI is 1154381929 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.